DrugPatentWatch Database Preview
Abatacept - Biologic Drug Details
Try a free trial
See Plans and Pricing
Summary for abatacept
| Tradenames: | 1 |
| Patents: | 65 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for abatacept |
Pharmacology for abatacept
| Ingredient-type | Recombinant Fusion Proteins |
| Physiological Effect | Decreased Cytokine Activity |
US Patents for abatacept
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | ➤ Sign Up | Momenta Pharmaceuticals, Inc. (Cambridge, MA) | 2029-01-22 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | ➤ Sign Up | University of Miami (Miami, FL) | 2030-10-19 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | ➤ Sign Up | OXFORD UNIVERSITY INNOVATION LIMITED (Oxford, GB) | 2034-01-13 | RX | search | |
| Bristol Myers Squibb | ORENCIA | abatacept | INJECTABLE; IV (INFUSION) | 125118 | 001 | 2005-12-23 | ➤ Sign Up | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for abatacept
Supplementary Protection Certificates for abatacept
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2008014,C1372696 | Lithuania | ➤ Sign Up | PRODUCT NAME: ABATACEPTUM; REGISTRATION NO/DATE: EU/1/07/389/001, 2007-05-21, EU/1/07/389/002, 2007-05-21, EU/1/07/389/003 20070521 |
| 0844 | Netherlands | ➤ Sign Up | PRODUCT NAME: IBRUTINIB, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/14/945 - C(2016)3293 20160530 |
| 0911 | Netherlands | ➤ Sign Up | PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170627 |
| 90021-0 | Sweden | ➤ Sign Up | PRODUCT NAME: IBRUTINIB ELLER ETT FARMACEUTISKT GODTAGBART SALT DAERAV; REG. NO/DATE: EU/1/14/945 20141023 |
| 2015 00021 | Denmark | ➤ Sign Up | PRODUCT NAME: IBRUTINIB ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/945 20141023 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
